Functions of RANKL/RANK/OPG in bone modeling and remodeling
Top Cited Papers
- 25 March 2008
- journal article
- review article
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 473 (2), 139-146
- https://doi.org/10.1016/j.abb.2008.03.018
Abstract
No abstract availableKeywords
This publication has 103 references indexed in Scilit:
- Osteoclast Precursor Interaction with Bone Matrix Induces Osteoclast Formation Directly by an Interleukin-1-mediated Autocrine MechanismJournal of Biological Chemistry, 2008
- Osteoprotegerin Inhibits Vascular Calcification Without Affecting Atherosclerosis in
ldlr
(−/−)
MiceCirculation, 2008
- RGS10-null mutation impairs osteoclast differentiation resulting from the loss of [Ca2+]i oscillation regulationGenes & Development, 2007
- Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systemsNature Reviews Immunology, 2007
- Positive regulatory domain I-binding factor 1 mediates repression of the MHC class II transactivator (CIITA) type IV promoterMolecular Immunology, 2007
- IFN-γ stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activationJournal of Clinical Investigation, 2007
- Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblastsJournal of Clinical Investigation, 2006
- Regulation of cancer cell migration and bone metastasis by RANKLNature, 2006
- Osteoclast differentiation and activationNature, 2003
- RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-βNature, 2002